ArticleOral oncology2022

Defining the optimal threshold and prognostic utility of pre-treatment hemoglobin level as a biomarker for survival outcomes in head and neck cancer patients receiving chemoradiation.

Sung Jun Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.